$0.624600
0.00460.74%
Pre-Market: Jul 19, 4:04 PM EDT
15 minutes delayed
Comments
Loading...
Quoin Pharmaceuticals
QNRXNASDAQ
Quoin Pharmaceuticals (NASDAQ:QNRX) Stock, Earnings Estimates, EPS, And Revenue
Quoin Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 5
EPS Estimate
$-0.610
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Quoin Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| QNRX | Quoin Pharmaceuticals | -$2.13 | -$0.61 | — | — | $0.00 | — | — | — | 08/05/2024 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$4.09 | -$0.76 | -$1.11 | -46.05% | $0.00 | — | $0.00 | — | 05/09/2024 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$4.92 | -$2.31 | -$2.08 | 9.96% | $0.00 | — | $0.00 | — | 03/13/2024 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$11.28 | -$2.72 | -$1.95 | 28.31% | $0.00 | — | $0.00 | — | 11/08/2023 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$38.88 | -$2.82 | -$2.13 | 24.47% | $0.00 | — | $0.00 | — | 08/02/2023 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$2.40 | -$3.36 | -$4.08 | -21.43% | $0.00 | — | $0.00 | — | 05/08/2023 | Get Alert |
| QNRX | Quoin Pharmaceuticals | — | -$7.44 | -$4.92 | 33.87% | — | — | $0.00 | — | 03/08/2023 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$16.80 | — | -$11.28 | — | $0.00 | — | $0.00 | — | 11/10/2022 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.00 | — | -$38.88 | — | $0.00 | — | $0.00 | — | 08/18/2022 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.00 | — | -$2.40 | — | $0.00 | — | $0.00 | — | 05/23/2022 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.00 | — | — | — | $0.00 | — | — | — | 04/22/2022 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.00 | — | -$16.80 | — | $0.00 | — | $0.00 | — | 12/20/2021 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.01 | — | -$0.00 | — | $0.00 | — | $0.00 | — | 08/24/2021 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.00 | — | -$0.00 | — | $0.00 | — | $0.00 | — | 05/17/2021 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.01 | — | -$0.00 | — | $0.00 | — | $0.00 | — | 03/29/2021 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.12 | — | -$0.00 | — | $0.00 | — | $0.00 | — | 11/20/2020 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.01 | — | -$0.01 | — | $0.00 | — | $0.00 | — | 08/12/2020 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.16 | — | -$0.00 | — | — | — | $0.00 | — | 05/21/2020 | Get Alert |
| QNRX | Quoin Pharmaceuticals | — | — | -$0.01 | — | — | — | $0.00 | — | 04/03/2020 | Get Alert |
| QNRX | Quoin Pharmaceuticals | — | — | -$0.12 | — | — | — | $0.00 | — | 11/19/2019 | Get Alert |
| QNRX | Quoin Pharmaceuticals | — | — | -$0.01 | — | — | — | $0.00 | — | 08/13/2019 | Get Alert |
Quoin Pharmaceuticals (QNRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-1.11 | $-0.76 | -46.1 % |
| Dec 2023 | 2024-03-13 | $-2.08 | $-2.31 | 9.96 % |
| Sep 2023 | 2023-11-08 | $-1.95 | $-2.72 | 28.3 % |
| Jun 2023 | 2023-08-02 | $-2.13 | $-2.82 | 24.5 % |
Quoin Pharmaceuticals (QNRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Quoin Pharmaceuticals (NASDAQ:QNRX) reporting earnings?
Quoin Pharmaceuticals (QNRX) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Quoin Pharmaceuticals (NASDAQ:QNRX)?
The Actual EPS was $-1.11, which missed the estimate of $-0.76.
What were Quoin Pharmaceuticals’s (NASDAQ:QNRX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.